IL-11 R alpha

IL-11 R alpha 분자 정보

영어 이름Interleukin 11 receptor alpha시판 약물 수9
임상 약물 수3표적 별명Interleukin-11 Receptor Alpha Chain,Interleukin 11 Receptor Subunit Alpha,Interleukin 11 Receptor, Alpha,IL-11R-Alpha,IL-11 Receptor Subunit Alpha,Interleukin-11 Receptor Subunit Alpha,IL11RA,IL-11RA,IL-11R Subunit Alpha,CRSDA,Interleukin-11 Receptor alpha Subunit,sIL-11RA,sIL-11R,sIL11RA
최고 연구 개발 단계Approved
영어 이름Interleukin 11 receptor alpha
표적 별명Interleukin-11 Receptor Alpha Chain,Interleukin 11 Receptor Subunit Alpha,Interleukin 11 Receptor, Alpha,IL-11R-Alpha,IL-11 Receptor Subunit Alpha,Interleukin-11 Receptor Subunit Alpha,IL11RA,IL-11RA,IL-11R Subunit Alpha,CRSDA,Interleukin-11 Receptor alpha Subunit,sIL-11RA,sIL-11R,sIL11RA
시판 약물 수9
임상 약물 수3
최고 연구 개발 단계Approved

IL-11 R alpha 제품 목록

  • 속성

    Protein (6)Cell (1)

  • 제품 라이브러리

    온라인 (7)

  • Human (4)Mouse (2)Rhesus macaque (1)

  • 태그

    Fc Tag (1)Fc Tag & Avi Tag (1)His Tag (2)- (1)Avi Tag (1)His Tag & Avi Tag (1)

  • 마커

    Unconjugated (3)Biotin-labeled (3)- (1)

IL-11 R alpha분자 배경

Interleukin-11 receptor subunit alpha (IL-11RA) is a type I transmembrane hematopoietic cytokine receptor serving as the ligand-specific binding subunit for IL-11. It harbors an extracellular cytokine-binding homology region, binds IL-11 with low affinity on its own, and recruits the shared, ubiquitously expressed signal-transducing coreceptor gp130 to assemble a functional high-affinity hexameric signaling complex upon ligand engagement. Widely expressed on stromal, epithelial and hematopoietic cells, IL-11RA mediates activation of JAK/STAT (predominantly STAT3), MAPK and PI3K pathways, governing critical biological processes including hematopoiesis, tissue damage repair and immune homeostasis, and is closely linked to fibrotic disorders and tumor progression.

IL-11 R alpha분자 별명

IL-11 R alpha,IL-11 RA,IL11RA,Interleukin-11 receptor subunit alpha,IL-11 receptor subunit alpha,IL-11R subunit alpha,IL-11R-alpha

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
Δ1-9, alanine 10, asparagine 134, recombinant human interleukin-11Phase 3 ClinicalFuzhou Quanye Economic Technology Co LtdThrombocytopenia
상세
LASN-01LASN-01Phase 2 ClinicalCsl LtdEndocrine System Diseases; Exophthalmos; Eye Diseases; Graves Ophthalmopathy; Pulmonary Fibrosis
상세
NMX-1NMX-1Phase 2 ClinicalNovomedix LLCTriple Negative Breast Neoplasms
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
Oprelvekin biosimilar (Hangzhou Jiuyuan Gene Engineering)ApprovedHangzhou Jiuyuan Gene Biomedical Co Ltd吉巨芬, JijufenMainland ChinaThrombocytopeniaHangzhou Jiuyuan Gene Biomedical Co Ltd2003-09-18Thrombocytopenia
상세
Recombinant human interleukin-11 (Qilu Pharmaceutical)ApprovedQilu Pharmaceutical Co Ltd巨和粒Mainland ChinaThrombocytopeniaQilu Pharmaceutical Co Ltd2003-03-18Thrombocytopenia
상세
Recombinant human interleukin-11 (Kerun Biopharmaceutical)ApprovedChongqing Kerun Biologic Pharmaceutical Development Co Ltd百杰依Mainland ChinaThrombocytopeniaChina Resources Angde Biotech Pharma Co Ltd2008-05-08Thrombocytopenia
상세
Recombinant human interleukin-11 (Beijing ShuangLu Pharmaceutical)ApprovedBeijing Sl Pharmaceutical Co Ltd迈格尔Mainland ChinaThrombocytopeniaBeijing Sl Pharmaceutical Co Ltd2003-03-17Thrombocytopenia
상세
Recombinant human interleukin-11 (Xiamen Amoytop Biotech)rHuIL-11ApprovedXiamen Amoytop Biotech Co Ltd特尔康Mainland ChinaThrombocytopeniaXiamen Amoytop Biotech Co Ltd2005-04-11Thrombocytopenia
상세
Recombinant human interleukin 11 (BioGeneric Pharma)ApprovedBiogeneic PharmaThrombocytopenia
상세
Recombinant human interleukin-11 for injectionApproved
상세
Recombinant human interleukin-11 (Shanghai CP Guojian)ApprovedSunshine GuoJian Pharmaceutical (Shanghai) Co Ltd欣美格Mainland ChinaThrombocytopeniaSunshine GuoJian Pharmaceutical (Shanghai) Co Ltd2005-04-26Thrombocytopenia
상세
Recombinant human interleukin-11 (Diao group)ApprovedChengdu Diao Jiuhong Pharmaceutical Factory依星Mainland ChinaThrombocytopeniaChengdu Diao Jiuhong Pharmaceutical Factory2003-04-23Thrombocytopenia
상세
  • 분자 정보
  • 제품 목록
  • 시판 약물 정보
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호